BOXBOROUGH, Mass.--(BUSINESS WIRE)--July 14, 2003--Cytyc Corporation (Nasdaq:CYTC - News) today announced the addition of Brock Hattox, Daniel J. Levangie, and Wayne Wilson to the Company's Board of Directors.
Mr. Hattox is the recent past chairman, chief executive officer, and president of National Service Industries, Inc., a diversified industrial company, a position he held from 2001 until July 2003. Mr. Hattox also served as executive vice president and chief financial officer of National Service Industries, prior to which he was senior vice president and chief financial officer at McDermott International, Inc., in New Orleans.
Mr. Levangie is president and chief executive officer of Cytyc Health Corporation, a wholly owned subsidiary of Cytyc Corporation. Mr. Levangie has served in a number of key executive roles at Cytyc since joining the company in 1992, including vice president of commercial operations and chief operating officer. Prior to joining Cytyc, Mr. Levangie held sales and marketing management positions at Abbott Laboratories.
Mr. Wilson is a certified public accountant and independent business advisor. He served as president and chief operating officer of PC Connection, Inc., a publicly traded, direct marketer of information technology products and services, from 1998 to September 2002, and previously served as its senior vice president of finance and chief financial officer. Prior to PC Connection, Mr. Wilson was a partner in the assurance and advisory services practice of Deloitte & Touche LLP.
"We expect the addition of Brock, Dan, and Wayne to further strengthen our Board of Directors," said Patrick J. Sullivan, Cytyc Corporation's chairman, president, and chief executive officer. "Dan's contribution to the company over the years has impacted every segment of our business. Brock and Wayne will further increase both the diversity and financial expertise on the Company's Board. We are fortunate to have such well qualified individuals to help guide the Company to continued growth and success."
Cytyc Corporation designs, develops, manufactures, and markets the ThinPrep® System for use in medical diagnostic applications primarily focused on women's health. The ThinPrep System is widely used for cervical cancer screening and is the platform from which the Company has launched its expansion into breast cancer risk assessment with the FirstCyte(TM) Breast Test. The ThinPrep System consists of the ThinPrep® 2000 Processor, ThinPrep® 3000 Processor, ThinPrep® Imaging System, and related reagents, filters, and other supplies. Cytyc is traded on The Nasdaq Stock Market under the symbol CYTC.
Cytyc and ThinPrep are registered trademarks of Cytyc Corporation. FirstCyte is a trademark of Cytyc Corporation for which registration has been applied.
Contact:
Cytyc Corporation
Robert Bowen, Chief Financial Officer
Anne Rivers, Investor Relations
Jeff Keene, Healthcare Media
978-266-3010
www.cytyc.com
